Trial Outcomes & Findings for Evaluation of Extended Wear Technology (NCT NCT04882800)

NCT ID: NCT04882800

Last Updated: 2022-12-14

Results Overview

Subjective ratings of comfort of each device in the ear, on a scale from 0 (very comfortable) to 10 (very uncomfortable/painful). No statistical analysis was planned for this measure.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

15 participants

Primary outcome timeframe

Two weeks after fitting device A in right ear/device B in left ear (Day 14 of study), and two weeks after fitting device A in left ear/device B in right ear (Day 28 of study-final appointment)

Results posted on

2022-12-14

Participant Flow

Participant milestones

Participant milestones
Measure
Intervention
Participants will be fit with commercially available Lyric extended wear hearing aid device A in right ear and Lyric extended wear hearing aid with fitting modification device B in left ear for two weeks (Day 1- Day 14 of study). They will then switch and be fit with device B in the right ear and device A in the left ear for two weeks (Day 15-Day 28 of study). Lyric extended wear hearing aid device A: Current commercially available extended wear hearing aid Lyric extended wear hearing aid with fitting modification device B: Extended wear hearing aid with fitting modifications
Device A Right Ear/Device B Left Ear
STARTED
15
Device A Right Ear/Device B Left Ear
COMPLETED
15
Device A Right Ear/Device B Left Ear
NOT COMPLETED
0
Device B Right Ear/Device A Left Ear
STARTED
15
Device B Right Ear/Device A Left Ear
COMPLETED
15
Device B Right Ear/Device A Left Ear
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
All Study Participants
n=15 Participants
All participants who were fit with hearing aid device A in right ear and hearing aid device B in left ear Day 1 to Day 14 of study, and then fit with device B in the right ear and device A in the left ear Day 15 to Day 28 of study. Lyric extended wear hearing aid device A: Current commercially available extended wear hearing aid Lyric extended wear hearing aid with fitting modification device B: Extended wear hearing aid with fitting modifications
Age, Continuous
68 years
n=15 Participants
Sex: Female, Male
Female
8 Participants
n=15 Participants
Sex: Female, Male
Male
7 Participants
n=15 Participants
Region of Enrollment
United States
15 participants
n=15 Participants

PRIMARY outcome

Timeframe: Two weeks after fitting device A in right ear/device B in left ear (Day 14 of study), and two weeks after fitting device A in left ear/device B in right ear (Day 28 of study-final appointment)

Population: All participants who were fit with commercially available Lyric extended wear hearing aid device A in right ear and Lyric extended wear hearing aid device B in left ear Day 1- Day 14, and who were fit with extended wear hearing aid device B in right ear and commercially available hearing aid device A in left ear Day 15 to Day 28 of study.

Subjective ratings of comfort of each device in the ear, on a scale from 0 (very comfortable) to 10 (very uncomfortable/painful). No statistical analysis was planned for this measure.

Outcome measures

Outcome measures
Measure
Intervention
n=30 Ears
Participants fit with commercially available Lyric extended wear hearing aid device A in right ear and Lyric extended wear hearing aid with fitting modification device B in left ear for two weeks,(Day 1 to Day 14 of study). They will then switch and be fit with device B in right ear and device A in left ear for two weeks (Day 15-Day 28 of study). Lyric extended wear hearing aid device A: Current commercially available extended wear hearing aid Lyric extended wear hearing aid with fitting modification device B: Extended wear hearing aid with fitting modifications
Subjective Questionnaire of Comfort
Comfort Rating of Device A
0 score on a scale
Interval 0.0 to 7.0
Subjective Questionnaire of Comfort
Comfort Rating of Device B (investigational device)
0 score on a scale
Interval 0.0 to 10.0

PRIMARY outcome

Timeframe: Two weeks after fitting device A in right ear/device B in left ear (Day 14 of study), and two weeks after fitting device A in left ear/device B in right ear (Day 28 of study-final appointment)

Population: All participants who were fit with commercially available Lyric extended wear hearing aid device A in right ear and Lyric extended wear hearing aid device B in left ear Day 1- Day 14, and who were fit with extended wear hearing aid device B in right ear and commercially available hearing aid device A in left ear Day 15 to Day 28 of study.

Subjective ratings on how plugged participants' ears felt with each device in ear,on scale from 0 (not at all) to 10 (extremely plugged/cannot tolerate)

Outcome measures

Outcome measures
Measure
Intervention
n=30 Ears
Participants fit with commercially available Lyric extended wear hearing aid device A in right ear and Lyric extended wear hearing aid with fitting modification device B in left ear for two weeks,(Day 1 to Day 14 of study). They will then switch and be fit with device B in right ear and device A in left ear for two weeks (Day 15-Day 28 of study). Lyric extended wear hearing aid device A: Current commercially available extended wear hearing aid Lyric extended wear hearing aid with fitting modification device B: Extended wear hearing aid with fitting modifications
Subjective Ratings of Occlusion With Both Devices
Occlusion Rating with Device A
0 score on a scale
Interval 0.0 to 8.0
Subjective Ratings of Occlusion With Both Devices
Occlusion Rating with Device B (fitting modification)
0 score on a scale
Interval 0.0 to 10.0

Adverse Events

First Intervention (Device A in Right Ear and Device B in Left Ear)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Second Intervention (Device B in Right Ear and Device A in Left Ear)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Principal Investigator

Sonova US

Phone: 630-821-5000

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place